Microcephaly-brain defect-spasticity-hypernatremia syndrome is a rare congenital genetic syndrome with a central nervous system malformation as a major feature characterized by microcephaly, hypertoni...
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
European rare disease database
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 4 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning microcephaly-brain defect-spasticity-hypernatremia syndrome
Updated Dec 14, 2017
Children born with microcephaly due to congenital Zika virus infection encounter significant health and developmental challenges by 19-24 months of age. This highlights the ongoing need for support and resources for affected families.
CDC allocates nearly $184 million to combat Zika virus and its associated health risks, including microcephaly. This funding will support various states, territories, and universities in their efforts to protect public health.
A study reveals a four-fold increase in microcephaly cases in Colombia following the 2016 Zika virus outbreak, indicating that the risk is highest among pregnant women infected early in their pregnancy. This finding underscores the broader impact of Zika virus outbreaks beyond Brazil.
CDC researchers, alongside US and Brazilian teams, have documented cases of microcephaly onset after birth in infants with congenital Zika virus infection. This study highlights the ongoing neurological complications associated with Zika, emphasizing the need for continued surveillance.
CDC allocates $2.4 million to five jurisdictions, including Chicago and New York City, to improve systems for detecting microcephaly and other outcomes related to Zika virus infection. This funding aims to enhance public health responses to the ongoing challenges posed by Zika.